Spruce Biosciences, Inc. (SPRB) Financials
Stock symbol SPRB is outdated, potentially delisted? Maybe it is available on other exchange?
SPRB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2025 | 31.6 million | 16.3 million |
| Dec. 31, 2024 | 45.2 million | 16.4 million |
| Sept. 30, 2024 | 65.1 million | 13.5 million |
| June 30, 2024 | 75.5 million | 16.4 million |
SPRB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2025 | -12.7 million | 544000 |
| Dec. 31, 2024 | -20.7 million | 961000 |
| Sept. 30, 2024 | -9.2 million | 1.1 million |
| June 30, 2024 | -11.1 million | 1.7 million |
SPRB Net Income
No data available :(
SPRB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2025 | 25.6 million | 659000 | 950000 |
| Dec. 31, 2024 | 38.8 million | 860000 | 1.0 million |
| Sept. 30, 2024 | 60.1 million | 1.3 million | 1.1 million |
| June 30, 2024 | 69.7 million | 1.8 million | 1.1 million |
SPRB Shares Outstanding
SPRB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2025 | - | 10.8 million | 3.7 million | - |
| Dec. 31, 2024 | - | 21.5 million | 3.3 million | - |
| Sept. 30, 2024 | - | 6.6 million | 3.5 million | - |
| June 30, 2024 | - | 8.1 million | 3.6 million | 12000 |
SPRB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2025 | 697000 | - |
| Dec. 31, 2024 | 697000 | - |
| Sept. 30, 2024 | 602000 | - |
| June 30, 2024 | 1.6 million | 8.1 million |
SPRB
Price: $8.92
52 week price:
Earnings Per Share: -99.75 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 65629
Market Capitalization: 5.1 million